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Introduction
Familial adenomatous polyposis (FAP) is an autosomal domi-
nant disorder characterized by gastrointestinal polyposis, bony
osteomata, epidermoid cysts, desmoid tumours, supernumery
teeth and odontomes. Desmoid tumours may occur in the
mesentery and retroperitoneal area, as well as in abdominal
wall aponeurosis, occasionally leading to intestinal obstruc-
tion and, rarely, to obstructive uropathy of the upper urinary
tract. Thirteen of 119 patients with FAP in the Singapore
Polyposis Registry had concomitant desmoid tumours. Two
cases with the complication of obstructive uropathy are re-
ported and 14 literature cases are reviewed to evaluate the best
approach to this difficult problem.
Case reports
Case 1
A 21-year-old female with FAP underwent laparoscopic re-
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storative proctocolectomy with ileo-anal pouch. Focal Duke’s
A adenocarcinoma of the colon was found. A 5.6-cm lower
rectus sheath desmoid tumour was found 2.5 years after sur-
gery and confirmed by biopsy. Mesenteric masses infiltrated
around the left common iliac vessels with resulting left hy-
dronephrosis and hydroureter. Progression of the desmoplas-
tic process compressing bilateral ureters at the bifurcation of
her iliac vessels was noted despite use of sulindac and tamoxifen
(Figure 1). Bilateral percutaneous nephrostomy followed by
double-J stenting normalized renal function. Her mesenteric
and rectus desmoid tumours progressed, however, with result-
ant duodenal obstruction requiring gastrojejunostomy bypass.
She required 4-monthly changing of bilateral encrusted stents,
but remains unobstructed despite development of new pelvic
desmoid tumours.
Case 2
A 33-year-old female with FAP underwent proctocolectomy
with J-pouch in 1994. Subsequent operations for anastomotic
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Discussion
Gardner’s syndrome was described by E.J. Gardner and R.C.
Richards in 1953, but is now better known as FAP. The abso-
lute risk of a desmoid tumour in FAP is 2.56/1,000 person
years and the comparative risk is 852 times that of the general
population.1 Desmoid tumours are more common in females
(4:1 sex ratio).2
Our two patients and 14 cases in the literature of desmoid
tumour with obstructive uropathy in patients with FAP had a
mean age of 26 years (range, 15–44) at the time of primary
surgery (Table).2–10 Desmoid tumours were identified at an
average of 2.2 years after primary surgery (6 months to 13
years). Twelve patients were followed up for between 4 months
and 11 years post-urological intervention.
Six patients had both extra- and intra-abdominal desmoid
tumours, nine had intra-abdominal tumours, and one patient
had a retroperitoneal desmoid tumour. All patients had
had prior surgery. Surgical manipulation appears to play a
role in causing desmoid tumours. The cumulative risk of post-
operative desmoid tumours has been reported by Lynch and
Fitzgibbons to be 16% at 10 years after colectomy.1
All ureteral obstructions were caused by intra-abdominal
desmoid tumours. Twelve patients had unilateral obstruction,
four of which were due to recurrent desmoid tumours. Four
had bilateral ureteral obstruction with unresectable desmoids.
Surgical resection was not possible in nine patients. Five
partial resections were performed but the desmoid tumours
recurred in three patients. Two of these recurrences caused
ureteral obstruction. The only patient with partial resection
and tumour remission had received doxorubicin and da-
leak and chronic pelvic abscess revealed desmoid tumours,
and the larger of the two was resected in 1996. Computed
tomography (CT) scan in July 2000 revealed a large (5 cm)
lobulated desmoid tumour arising from the right rectus mus-
cle at the L4 level, together with a pelvic abscess to the right of
the bladder. CT scan 3 months later showed no interval change,
but left hydronephrosis was noted. Sulindac and tamoxifen
were prescribed for 2 months but disease progression was
noted in January 2002 (Figure 2). Percutaneous nephrostomy
was performed for pyonephrosis, and a double-J stent was
internalized 5 days later. She was discharged from hospital
with sulindac and tamoxifen, and was well with normal serum
creatinine during her subsequent outpatient stent changes in
June and November 2002. The left rectus desmoid tumour
continued to enlarge.
Figure 1. (A) Lower rectus sheath desmoid tumour (arrowhead) with mesenteric desmoplastic process; (B) resultant bilateral hydro-
nephrosis with hydroureter (arrows).
Figure 2. Left hydronephrosis-hydroureter (arrow) secondary to
15 = 12.3 = 10.1-cm desmoid tumour arising from the left rectus
muscle (arrowhead), breaching the ventral peritoneum inferiorly.
The smaller right tumour measures 5.6 = 2.3 = 9.0 cm.
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carbazine.5 The two patients with complete resection subse-
quently had tumour recurrence with ureteral obstruction.
Local recurrence following excision in these patients (71%,
5/7) appeared to be higher than the reported 25%.11
Surgical intervention for obstructive uropathy includes
nephroureterectomy,4 ureteral resection,4 ureterolysis8 and
renal autotransplantation7 (Table). The patient with the
nephroureterectomy, partial desmoid resection and prophy-
lactic contralateral ureteral stenting had tumour recurrence
during follow-up.4 Progression of disease was also reported
9 months after ureterolysis.8 On the other hand, the patient
whom Lattimer et al autotransplantated for ureteral stent
obstruction had excellent renal function at 2 years.7
Percutaneous nephrostomy (PCN) of the obstructed sys-
tem was used by McAdam and Goligher.2 Although a 28-year-
old patient died despite haemodialysis, this treatment proved
beneficial to subsequent patients (Patients 1–4, Table), who
had PCN and ureteral stenting for unresectable desmoids.
These patients recovered without open surgery. One was lost
to follow-up, while another had partial response with ibuprofen
and tamoxifen. Both our patients were urologically well 10
and 18 months post-stenting, respectively, despite desmoid
progression. Stents have also been used successfully to treat
desmoid-ureteral fistulas.3 Two patients had ureteral stenting
with partial desmoid resection; one went into remission with
combination chemotherapy (Patient 7), while the other had
recurrence without obstruction (Patient 5).
Unresectable desmoids may require medical therapy.5,12
Chemotherapy has not been studied extensively due to the
relative rarity of desmoid tumours. Lynch et al reported suc-
cess with adjuvant combination doxorubicin and dacarbazine
in a patient where tamoxifen failed (Patient 7).5 The one pa-
tient who received cobalt therapy reported moderate subjec-
tive relief (Patient 16).7 Three patients who received non-
steroidal anti-inflammatory drugs and tamoxifen did not
show demonstrable response (Patients 1–3, Table). Both our
patients progressed to complicated obstructive uropathy de-
spite being treated with sulindac and tamoxifen.
Two of three patients who subsequently died succumbed
to complications of obstructive uropathy at the ages of 28
and 30 years (17 months after complete desmoid resec-
tion).6
Desmoid tumour-associated ureteral obstruction in FAP
is an affliction of the young. Surgical manipulation is a risk
factor for desmoid formation. Although wide local resection
has been advocated, radical surgery is not advisable in view of
tumour recurrence. Ureteral stenting appears to be effective
and safe. The convenience of outpatient stent replacement
makes it even more attractive for long-term management.
Adjuvant medical therapy should be considered for patients
with partially resectable or unresectable desmoid tumours
treated with ureteral stents, but the optimal regimen requires
further evaluation.
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